• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性厚甲症各亚型在管理、对患者的影响及临床特征方面的差异。

Distinctions in the Management, Patient Impact, and Clinical Profiles of Pachyonychia Congenita Subtypes.

作者信息

Wu Albert G, Lipner Shari R

机构信息

New York Medical College, New York, New York, USA.

Department of Dermatology, Weill Cornell Medicine, New York, New York, USA.

出版信息

Skin Appendage Disord. 2021 Apr;7(3):194-202. doi: 10.1159/000513340. Epub 2021 Feb 5.

DOI:10.1159/000513340
PMID:34055907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8138248/
Abstract

INTRODUCTION

Pachyonychia congenita (PC) is a rare dermatosis that confers lifelong physical and emotional morbidities in affected patients. However, the clinical findings, treatments, and psychosocial impact of this disease have not been adequately described. The International PC Research Registry (IPCRR), a multinational initiative to collect data on PC patients, has allowed an opportunity to distinguish the salient features of this disease. We aimed to characterize the breadth and extent of nail disease, treatments, and quality of life in PC patients, and to describe any significant differences in clinical presentation or treatment of PC subtypes.

METHODS

The most recent IPCRR patient survey data consisting of an 857-response questionnaire and a 102-response addendum were analyzed in a retrospective analysis. The survey data were collected as part of a multinational, multicenter initiative and comprise the largest representative population of PC to date. Participants (survey respondents) were included in the study based on questionnaire responses and a genetic confirmation of having a PC subtype.

RESULTS

A total of 857 survey responses were collected. Genetic variations among PC subtypes influence nail disease onset and severity of symptoms. Nail disease negatively impacts patients' emotional health, especially during the adolescent and young adult years. Nail treatment tools vary little in terms of effectiveness and acquired infection rates.

CONCLUSION AND DISCUSSION

Patients with different PC subtypes have distinct clinical nail presentations and psychosocial impact. Genetic testing should be used to confirm PC diagnoses. Further characterization of PC, especially the rarer subtypes, may allow for more individualized patient education.

摘要

引言

先天性厚甲症(PC)是一种罕见的皮肤病,给受影响的患者带来终身的身体和情感疾病。然而,这种疾病的临床发现、治疗方法以及社会心理影响尚未得到充分描述。国际先天性厚甲症研究注册库(IPCRR)是一项收集先天性厚甲症患者数据的跨国倡议,它为区分这种疾病的显著特征提供了契机。我们旨在描述先天性厚甲症患者指甲疾病的范围和程度、治疗方法以及生活质量,并描述先天性厚甲症各亚型在临床表现或治疗方面的任何显著差异。

方法

对国际先天性厚甲症研究注册库最新的患者调查数据进行回顾性分析,这些数据包括一份有857份回复的问卷和一份有102份回复的附录。该调查数据是作为一项跨国、多中心倡议的一部分收集的,是迄今为止最大的先天性厚甲症代表性人群。根据问卷回复以及对患有先天性厚甲症某一亚型的基因确认,将参与者(调查对象)纳入研究。

结果

共收集到857份调查回复。先天性厚甲症各亚型之间的基因变异会影响指甲疾病的发病和症状严重程度。指甲疾病对患者的情绪健康有负面影响,尤其是在青少年和青年时期。指甲治疗工具在有效性和感染率方面差异不大。

结论与讨论

不同先天性厚甲症亚型的患者有不同的临床指甲表现和社会心理影响。应使用基因检测来确诊先天性厚甲症。对先天性厚甲症,尤其是较罕见亚型的进一步特征描述,可能有助于开展更具个性化的患者教育。

相似文献

1
Distinctions in the Management, Patient Impact, and Clinical Profiles of Pachyonychia Congenita Subtypes.先天性厚甲症各亚型在管理、对患者的影响及临床特征方面的差异。
Skin Appendage Disord. 2021 Apr;7(3):194-202. doi: 10.1159/000513340. Epub 2021 Feb 5.
2
Pachyonychia congenita in pediatric patients: natural history, features, and impact.先天性厚甲症在儿科患者中的自然病史、特征和影响。
JAMA Dermatol. 2014 Feb;150(2):146-53. doi: 10.1001/jamadermatol.2013.6448.
3
Pachyonychia congenita patients with mutations in KRT6A have more extensive disease compared with patients who have mutations in KRT16.先天性厚甲症患者中,KRT6A 基因突变者的疾病比 KRT16 基因突变者更为广泛。
Br J Dermatol. 2012 Apr;166(4):875-8. doi: 10.1111/j.1365-2133.2011.10745.x.
4
The histopathological features of the nail plate in pachyonychia congenita.先天性厚甲症中甲板的组织病理学特征。
J Cutan Pathol. 2020 Apr;47(4):357-362. doi: 10.1111/cup.13630. Epub 2020 Jan 9.
5
Revisiting pachyonychia congenita: a case-cohort study of 815 patients.再探先天性厚甲症:一项针对815例患者的病例队列研究。
Br J Dermatol. 2020 Mar;182(3):738-746. doi: 10.1111/bjd.18794. Epub 2020 Jan 14.
6
First case of pachyonychia congenita in the Czech Republic.捷克共和国先天性厚甲症首例病例。
Dermatol Ther. 2015 Jan-Feb;28(1):10-2. doi: 10.1111/dth.12142. Epub 2014 Aug 29.
7
Transgrediens pachyonychia congenita (PC): case series of a nonclassical PC presentation.Transgrediens 型先天性厚甲症(PC):非典型 PC 表现的病例系列。
Br J Dermatol. 2012 Jan;166(1):124-8. doi: 10.1111/j.1365-2133.2011.10537.x.
8
Pachyonychia Congenita: A Spectrum of KRT6a Mutations in Australian Patients.先天性厚甲症:澳大利亚患者中KRT6a基因突变谱
Pediatr Dermatol. 2016 May;33(3):337-42. doi: 10.1111/pde.12841. Epub 2016 Apr 4.
9
Identification of clinically useful predictive genetic variants in pachyonychia congenita.鉴定先天性厚甲症中有临床应用价值的预测性遗传变异。
Clin Exp Dermatol. 2021 Jul;46(5):867-873. doi: 10.1111/ced.14569. Epub 2021 Mar 17.
10
The phenotypic and molecular genetic features of pachyonychia congenita.先天性厚甲症的表型和分子遗传学特征。
J Invest Dermatol. 2011 May;131(5):1015-7. doi: 10.1038/jid.2011.59. Epub 2011 Mar 24.

引用本文的文献

1
Pediatric Nail Disorders.小儿指甲疾病
Skin Appendage Disord. 2024 Oct;10(5):342-356. doi: 10.1159/000538835. Epub 2024 May 22.

本文引用的文献

1
A treatment protocol for botulinum toxin injections in the treatment of pachyonychia congenita-associated keratoderma.用于治疗先天性厚甲症相关角化病的肉毒杆菌毒素注射治疗方案。
Br J Dermatol. 2020 Mar;182(3):671-677. doi: 10.1111/bjd.18169. Epub 2019 Sep 8.
2
Genetic and developmental disorders of the oral mucosa: Epidemiology; molecular mechanisms; diagnostic criteria; management.口腔黏膜的遗传和发育障碍:流行病学;分子机制;诊断标准;治疗。
Periodontol 2000. 2019 Jun;80(1):12-27. doi: 10.1111/prd.12261.
3
A systematic review of reported cases of pachyonychia congenita tarda.迟发性先天性厚甲症的病例报告系统综述。
Clin Exp Dermatol. 2019 Aug;44(6):606-612. doi: 10.1111/ced.13980. Epub 2019 May 10.
4
Pathophysiology of pachyonychia congenita-associated palmoplantar keratoderma: new insights into skin epithelial homeostasis and avenues for treatment.先天性厚甲症相关掌跖角化病的病理生理学:皮肤上皮稳态的新见解及治疗途径
Br J Dermatol. 2020 Mar;182(3):564-573. doi: 10.1111/bjd.18033. Epub 2019 Jul 24.
5
Keratin 6a mutations lead to impaired mitochondrial quality control.角蛋白6a突变导致线粒体质量控制受损。
Br J Dermatol. 2020 Mar;182(3):636-647. doi: 10.1111/bjd.18014. Epub 2019 Jul 21.
6
Pachyonychia Congenita Associated with a Novel Variant of KRT17 Presenting Unusual Oral Manifestations.先天性厚甲症与KRT17的一种新型变体相关,表现出不寻常的口腔表现。
J Dent Child (Chic). 2019 Jan 15;86(1):61-63.
7
A KRT16 mutation in the first Chinese pedigree with Pachyonychia congenita and review of the literatures.一个 KRT16 突变在第一个中国人常染色体显性遗传性厚甲症家系中的发现及文献复习
J Cosmet Dermatol. 2019 Dec;18(6):1930-1934. doi: 10.1111/jocd.12905. Epub 2019 Mar 12.
8
Novel mutations in desmoglein 1: focal palmoplantar keratoderma in milder phenotypes.桥粒芯糖蛋白1的新型突变:较轻表型的局限性掌跖角化病
Br J Dermatol. 2019 Sep;181(3):618-620. doi: 10.1111/bjd.17839. Epub 2019 Jun 2.
9
Pachyonychia congenita: a case report of a successful treatment with rosuvastatin in a patient with a KRT6A mutation.先天性厚甲症:一例 KRT6A 突变患者使用瑞舒伐他汀成功治疗的病例报告。
Br J Dermatol. 2019 Sep;181(3):584-586. doi: 10.1111/bjd.17276. Epub 2018 Dec 2.
10
Novel and recurrent mutations in keratin 1 cause epidermolytic ichthyosis and palmoplantar keratoderma.角蛋白 1 中的新型和反复突变导致表皮松解性鱼鳞病和掌跖角化过度症。
Clin Exp Dermatol. 2019 Jul;44(5):528-534. doi: 10.1111/ced.13800. Epub 2018 Oct 4.